Wallachbeth capital announces pricing of bioaffinity technologies public offering for $4.8m

Jersey city, n.j. , sept. 29, 2025 /prnewswire/ -- wallachbeth capital llc, a leading provider of capital markets and institutional execution services, announced today that bioaffinity technologies, inc. (nasdaq: biaf and biafw) a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer has priced a public offering of securities as described below for aggregate gross proceeds to the company of $ million, before deducting agent fees and other estimated expenses payable by the company.
BIAF Ratings Summary
BIAF Quant Ranking